Method and barrier for limiting fluid movement through a tissue rent

ABSTRACT

A method and device provides for limiting fluid movement through a rent in a membranous tissue by forming a biocompatible and biodegradable barrier at the site of the rent. The barrier is formed by inserting into the rent a plug that includes connected water-swellable parts, so that within a short time following placement of the plug at the site the swellable parts expand in situ to form the barrier and occlude the rent. As fluids near the site are taken up by the swellable material, the material expands rapidly to fill the rent, engaging the marginal surfaces of the membrane near the edges of rent and forming a secure barrier at the site. All the materials of the plug are biocompatible and, over a period of time that allows for healing of the rent, all the components of the barrier are completely degraded without leaving any residual material at the site.

CROSS-REFERENCE TO RELATED APPLICATION

This application is a Divisional of U.S. application Ser. No.10/114,662, filed 1 Apr. 2002.

BACKGROUND

This invention relates to limiting fluid movement through rents in bodytissues, and particularly the invention relates to providing a barrierfor fluid movement through a puncture in a membranous tissue such as thedura mater.

For many medical procedures, access to an internal body cavity is madeby way of a puncture or other opening in the wall or membrane enclosingthe body cavity. Following such a procedure, fluids or fluid-bornematerials may pass through the opening or rent, and complications mayresult. Reliable methods are needed for limiting movement of fluids orfluid-borne materials across openings in membranes enclosing bodycavities, to mitigate such complications.

The mammalian brain and spinal cord are closely invested by a membranetermed the pia mater, and are surrounded by a thick inelastic membranetermed the dura mater. A delicate membrane termed the arachnoid envelopsthe brain and spinal cord between the dura mater and the pia mater. Thearachnoid is separated from the pia mater by the so-called intrathecalor subarachnoid space, which is filled with cerebrospinal fluid (“CSF”).The intrathecal space is accessed clinically, usually by a percutaneousneedle puncture through the dura, for a wide variety of purposes,including collection of CSF for chemical and cytological analysis anddelivery of therapeutic agents. Percutaneous needle puncture through thedura is one of the most common procedures performed in clinicalmedicine.

Intraspinal administration of anesthetics and analgesics has beenperformed for over one hundred years; it has in recent years come intoincreasing use in obstetrics, urology, and orthopedics, and it is now amainstay of therapy in the rapidly growing field of pain management.

Diagnostic myelography is commonly employed prior to all types of spinalsurgery, entailing injection of radiographic contrast material into theintrathecal space. The intrathecal space also provides a depot foradministration of chemotherapy, and rapid advances in neurobiologypromise a range of new therapies directed at degenerative centralnervous system conditions. Diseases such as multiple sclerosis,amyelotrophic lateral sclerosis (Lou Gehrig's disease), Alzheimer'sdisease, and others, will likely generate increased need for intrathecalaccess to permit delivery of drugs that may not easily cross theblood-brain barrier.

Headache is the most common complication of dural puncture. Thepathogenesis of post dural puncture headache (PDPH) is generallybelieved to be related to ongoing CSF leak at the site of the duralpuncture, although the mechanism of pain is not clear. Low CSF pressuremay result in traction on pain sensitive structures, especially wherethe subject is in the upright position, caused by loss of the cushioningeffect of the normal CSF volume. Vascular dilatation in response to lowCSF volume may also be a factor, and neurohumeral responses have beenimplicated as well. Whatever the cause or causes may be, the reportedincidence of PDPH ranges from two percent to 75 percent, depending on avariety of epidemiological factors, including the age, gender, andmedical condition of the patient. Women are more likely than men tosuffer PDPH, and the rate of PDPH is more likely in younger than inolder adults; and it is therefore unsurprising that PDPH is asignificant problem following spinal anesthesia in the obstetricalpopulation.

Technical factors may play an important role in generation of PDPH,including needle diameter, needle tip configuration, preparation of theskin, and characteristics of injected material. Incidence of PDPH can bereduced by employing a smaller needle (gauge 25 or higher) or byemploying a needle having a “pencil tip” with a side port; and somepractitioners have recommended orienting the needle in parallel with thedural fibers. The use of small needles as an approach to reducing theoccurrence of PDPH is limited by the greater technical difficulty(especially for non-anesthesiologists) of achieving successful duralpuncture using smaller needles; and viscosity of some injectates(myelography dies, for example) is too high to permit the use of smallerneedles. Even where optimal technique is employed in low riskpopulations, the incidence of PDPH is reported as five to 20 percent ormore in most studies.

The pain due to PDPH is typically severe and long-lasting, and it can becompletely disabling in some instances for days to weeks following thedural puncture procedure. PDPH pain can be relieved by maintaining thesubject in a supine position, and patients often are confined to bed forthe duration of the headache episode. Symptoms associated with PDPHinclude nausea and vomiting which predisposes the patient to dehydrationand impairs the patient's ability to replace lost CSF, prolonging thepainful syndrome. Visual disturbances, tinnitus, vertigo, neck stiffnessand auditory symptoms all contribute to the disability associated withPDPH. Severe traction on cranial nerves resulting from low CSF pressurecan cause significant palsy, particularly of the vi^(th) cranial nerve.Traction on intracranial vascular structures can result in potentiallyfatal intracranial hemorrhage, although this complication is rare. Thetypical onset of PDPH is 24-48 hours after the procedure, with aduration of three to four days, and approximately 75 percent of patientsexperience resolution of symptoms within seven days after onset,although it is not unusual for PDPH to last for weeks.

Types of treatment for PDPH generally fall into two categories.Nonspecific, supportive therapies including correction of dehydrationand administration of analgesics and anti-emetics are generallysufficient for mild PDPH, in conjunction with maintenance of a supineposition at bed rest. Corrective therapies include treatments designedto increase CSF volume and obtund the neurohumeral or vascular cause ofthe headache. Methylxanthenes such as caffeine and theophylline canconstrict cerebral venous channels and promote CSF production, and suchagents are often sufficient to control mild cases of PDPH.

The definitive treatment for PDPH, however, is to stop the leak byperforming an epidural blood patch. This involves drawing 10-20 cc ofsterile autologous blood and administering the blood via a standardepidural access procedure at the same spinal level. In theory, the bloodpatch halts the flow of CSF from the intrathecal space, reversing thepressure gradient from lumbar spine to cranial vault, and pushes theremaining CSF toward the brain to provide support for the intracranialstructures, thereby producing immediate relief. The success rate of thedural blood patch in mitigating PDPH is reported as 85-95 percent.Complications from the dural blood patch procedure are unusual, otherthan mild low back discomfort and stiffness, but there are case reportsof subdural hematoma, abscess formation, arachnoiditis, and evenblindness following repeat epidural blood patch. Attempts to employ anepidural blood patch prophylactically have uniformly failed to mitigatePDPH. And the epidural blood patch procedure is highly costly from aneconomic standpoint.

Accordingly, PDPH continues to be a very troublesome complication ofotherwise successful intrathecal access by dural puncture, which mayhave important implications for the patient's post-operative course. Forinstance, PDPH following cesarean section results in poorermaternal-infant bonding and inability to breast-feed. Diagnostic lumbarpuncture is frequently performed for diagnosis of headache, for exampleto rule out meningitis, and the presence of PDPH may seriously confoundefforts and diagnosis. PDPH is very costly in terms of lost days at workand diminished productivity, and additional days of hospitalization,economically burdening the patient and the employer as well as thehealth care and health insurance systems.

A need persists for a method of reliably preventing PDPH as acomplication of dural puncture procedures.

SUMMARY

The invention provides for limiting fluid movement through a rent in amembranous tissue by forming a biocompatible and biodegradable barrierat the site of the rent. According to the invention, the barrier isformed by inserting into the rent a plug that includes connectedwater-swellable parts, so that the swellable parts expand in situ toform the barrier and occlude the rent.

The invention can be employed in connection with any of the manyprocedures in which access to an internal body space is made by way of apuncture in a wall or membrane. Particularly, for example, the inventioncan be employed prophylactically at the conclusion of a conventionaldural access procedure.

The materials of which the plug is made are biocompatible. Generally, asdeployed according to the invention, the plug materials do not causesignificant cell injury or death; they do not cause an adverseinflammatory response; and they do not cause malignant cellulartransformation.

The materials of which the plug is made are biodegradable. Generally,the plug materials are capable of being broken down and removed from thesite by normal physiologic and cellular processes within the body of thesubject being treated, typically including for example dissolution inthe aqueous environment, leukocyte/macrophage macrocytosis, andenzymatic digestion. The degradation products are metabolized ortransferred away from the site ultimately through venous and lymphaticchannels. Preferably the degradation products and their metabolites arealso biocompatible. The plug or barrier materials do not persistpermanently at the site, and degradation and removal of residues of thematerial proceeds to completion over a course of time of weeks ormonths.

Plugs according to invention can be configured and dimensioned to formbarriers in rents having a wide range of dimensions and shapes, and inmembranes or walls having a wide range of thicknesses. The swellableparts are provided in a shape and size appropriate to the shape and sizeof the particular rent.

A plug according to the invention can be deployed by using a stylet topass the plug within the lumen of a needle or catheter to a point justbeyond the tip. The needle or catheter is then withdrawn over the styletand the plug is left in place at the puncture site. As fluids near thesite are taken up by the swellable material, the material expandsrapidly to fill the rent, engaging the marginal surfaces of the membranenear the edges of rent and forming a secure barrier at the site. All thematerials of the plug are biocompatible and, over a period of time thatallows for healing of the rent, all the components of the barrier arecompletely degraded without leaving any residual material at the site.

Accordingly, in one general aspect the invention features a method forlimiting fluid movement through a rent in a membranous tissue, byplacing within the rent a plug that includes connected water-swellableparts, so that the swellable parts expand in situ to occlude the rent.In some embodiments, the plug includes two swellable parts joined by aconnector, and the placement of the plug according to invention includespositioning the plug so that one swellable part is within a volumebounded by one surface of the membranous tissue and the other swellablepart is within a volume bounded by the opposite surface of themembranous tissue, and the connector traverses the rent.

The method can be particularly useful for forming a barrier in a rent inthe dura mater. The method can be employed for management of anintraspinal dural rent, or of an intracranial dural rent; includingmanagement of a rent at any point in the spinal dura (cervical,thoracic, lumbar, sacral), at any point along the spine from C1 to thesacrum, and including management of a puncture made at the foramenmagnum for a CSF tap. For closing a rent (such as a puncture) in thespinal dura, for example, the plug is positioned in the rent so that oneswellable part is within the subarachnoid space, and the other swellablepart is positioned in the epidural space, and the connector traversesthe puncture in the dura. Over a brief time (in the order of seconds tominutes) the parts swell in situ, so that the swollen parts fill theopening in the dura and engage the margin at the edge of the opening,forming the fixed barrier at the site. Thereafter, over a longer time(in the order of days to weeks or months), the barrier is degraded asthe rent heals, so that eventually the opening is closed and nothingremains of the barrier.

In some embodiments, the placement of the plug according to the methodincludes passing the plug through the lumen of a needle or catheter. Fortreating a puncture in the spinal dura, for example, the plug is placedby pushing it through the dural puncture needle.

The invention can be employed prophylactically at the conclusion of thedural puncture procedure, to occlude the dural defect and therebyinhibit the movement of CSF out from the intrathecal space and themovement of potentially complicating substances into the CSF through therent. Deployment of the plug through the dural puncture needle providesa dural rent management protocol that is highly reliable andreproducible. Because the size of the dural defect is related to thediameter of the dural puncture needle, sizing the plug according to thelumenal diameter of the needle can index and appropriate size for thebarrier that results from swelling of the plug in situ followingwithdrawal needle over the plug. The rent management protocol accordingto the invention does not require an additional skill set for theoperator beyond confidence in performing the dural puncture itself, andrequires only minimal elongation of the dural access procedure.

The plug materials according to the invention are selected for use inregions of the body for which their capacities for biocompatibility andbiodegradability are well known or readily ascertainable.

Plugs in a variety of lengths and diameters can be included in a spinalaccess tray or kit currently in use, without significant dedication ofthe current configurations of the tray or kit. No special apparatus isneeded for carrying out the method of the invention and, accordingly,the invention provides for a cost effective and convenient approach todural defect management that features a high level of reliability andsafety and a low potential for complication.

In another general aspect the invention features a biocompatible andbiodegradable plug body for insertion into a tissue rent to form abarrier to fluid movement through the rent, having a swellable portionincluding at least two connected water-swellable parts. In someembodiments the water-swellable parts are end portions of adumbbell-shaped body formed entirely of a water-swellable material; insome embodiments the water-swellable parts are beads formed on aconnecting filament.

In order to form an effective barrier, the swellable portion of the plugswells in situ from a size small enough that it can be deployed withinthe rent to a size sufficiently large that the swelled portions engagethe membrane or wall near the edges of the rent, and thereby secure thebarrier at the site. Accordingly, the material of which the swellableparts are formed is selected so that the swellable parts can increase insize in an aqueous medium (such as, for example, in a physiologicalsaline at about normal body temperature, comparable to conditions at thesite in the body of the subject being treated) at least 1.2 times in atransverse dimension, and in some embodiments as much as 10 times in atransverse dimension. In some embodiments swellable parts can increasein size in an aqueous medium to at least 1.3 times, in some embodimentsat least 2 times; and as much as 5 times, still more usually as much as3 times. In particular embodiments the swellable parts increase in sizein an aqueous medium about 1.2-3 times in a transverse dimension.

In some embodiments the material of which the swellable parts are formedincludes a biocompatible and biodegradable water-swellable polymer. Thewater-swellable polymer may be protein-based, or carbohydrate-based, ormineral-based. In some embodiments the water-swellable polymer is agelatin, a collagen, a cellulose, an agarose, a hyaluronic acid, apoly(vinyl alcohol) (PVA), a poly(ethylene oxide) (PEO), or the like.The material of which the swellable parts are formed can be a foamedgel, or a sponge or mesh, or the like.

In some embodiments the connecting filament is formed of a biocompatibleand biodegradable non water-swellable material, such as a polyglycolateor a polylactate or a polydioxanone, or the like. Preferably thefilament is a monofilament, rather than a multifilament. Convenientlythe connecting filament can be formed of an absorbable suture material,that is, a sterile filament prepared from collagen derived from ahealthy mammal, or a synthetic polymer, capable of being biodegraded byliving mammalian tissue.

In some embodiments the beads have a generally spheroidal or sphericalor ovoid shape; in some embodiments the beads are discoid in shape; inother embodiments the beads are elongated in an axial direction. Thebeads need not be separate from one another, and in some embodiments theswellable material is continuous between adjacent beads.

In some embodiments, where the plug is to be deployed through a needleor catheter, the swellable parts are sized small enough in a dimensiontransverse to the filament axis so that they can be passed readilywithin the lumen of the particular needle or catheter.

In some embodiments the swellable portion of the plug has a length atleast 6 millimeters, and more usually at least 10 millimeters; and insome embodiments the swellable portion of the plug has a length at most20 millimeters, and more usually at most 12 millimeters; in particularembodiment, for use for example in management of an intraspinal duralrent, the swellable portion of the plug has a length in the range 10 to12 millimeters.

Where the plug is to be deployed by passing it through the lumen of aneedle or catheter, the inside diameter of the deployment tool imposes alimit on the wider transverse dimension (for example, the transversediameter) of the swellable parts of the plug. The inside diameter of athin-walled 15 gauge needle, for example, may typically be about 1.5millimeters, requiring that a plug to be deployed through such a needlehave a maximum transverse dimension less than about 1.5 millimeters; andthe inside diameter of a thin-walled 27 gauge needle, for example, maytypically be about 0.2 millimeters, requiring that a plug to be deployedthrough such a needle have a maximum transverse dimension less thanabout 0.2 millimeters.

In some embodiments the swellable parts are pitched closely enoughtogether to enable any adjacent two of them to engage the margin at theedge of the rent as they swell. And in some embodiments they are pitchedat a distance apart at least equal to about the thickness of themembrane or wall that they are intended to traverse, to ensure that anadjacent pair of the swellable parts can span the thickness at the rent.

In some embodiments the connecting filament is sufficiently stiff thatit can serve as a stylet, and in such embodiments the filament mayextend well beyond the water swellable beaded portion. The stiffness ofthe filament will be characteristic of the material and the thickness ofthe filament.

The invention can be employed in conjunction with any of a variety ofmedical procedures during which an internal body space is accessed bypuncture or rent through a wall or membrane.

The invention can also be employed in conjunction with any of a varietyof medical procedures in which a puncture or rent is formedunintentionally. For example, the spinal dura may be unintentionallypunctured by the epidural needle in the course of preparing toadminister an anesthetic into the epidural space; according to theinvention, loss of CSF from the intrathecal space and movement ofanesthetic into the intrathecal space can be limited by forming abarrier in such a dural rent prior to completion of the procedure.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a diagrammatic sketch in a transverse sectional view thru aportion of the spine of a subject showing a plug in place according tothe invention at a dural puncture site.

FIG. 2 is a diagrammatic sketch of a portion of a sectional view as inFIG. 1, showing a barrier at the dural puncture site formed by swellingof the plug according to the invention.

FIG. 3 is a diagrammatic sketch in a lengthwise sectional view thru aplug in place at a dural puncture site according to an embodiment of theinvention.

FIG. 4 is a diagrammatic sketch in a lengthwise sectional view showing astage in the formation of a barrier from the plug of FIG. 3.

FIG. 5 is a diagrammatic sketch in a lengthwise sectional view thru abarrier formed at the site of a dural puncture from the plug of FIG. 3.

FIG. 6 is a diagrammatic sketch in a lengthwise sectional view thru aplug in place at a dural puncture site according to another embodimentof the invention.

FIG. 7 is a diagrammatic sketch in a lengthwise sectional view showing astage in the formation of a barrier from the plug of FIG. 6.

FIG. 8 is a diagrammatic sketch in a lengthwise sectional view thru abarrier formed at the site of a dural puncture from the plug of FIG. 6.

FIG. 9 is a diagrammatic sketch in a lengthwise sectional view thru aplug in place at a dural puncture site according to yet anotherembodiment of the invention.

FIG. 10 is a diagrammatic sketch in a lengthwise sectional view showinga stage in the formation of a barrier from the plug of FIG. 9.

FIG. 11 is a diagrammatic sketch in a lengthwise sectional view thru abarrier formed at the site of a dural puncture from the plug of FIG. 9.

FIGS. 12-15 are diagrammatic sketches in a lengthwise sectional viewshowing stages in placement of a plug at a dural puncture site accordingto an embodiment of the invention.

FIG. 16 is a diagrammatic sketch in a lengthwise sectional view thru aplug in place at a dural puncture site according to yet anotherembodiment of the invention.

FIG. 17 is a diagrammatic sketch in a lengthwise sectional view showinga stage in the formation of a barrier from the plug of FIG. 16.

FIG. 18 is a diagrammatic sketch in a lengthwise sectional view thru abarrier formed at the site of a dural puncture from the plug of FIG. 16.

FIGS. 19-20 are diagrammatic views in sectional views thru a portion ofa plug according to the invention, marked for reference to dimensions.

FIGS. 21-30 are diagrammatic sketches in side views (21, 23, 25, 27, 29)and axial views (22, 24, 26, 28, 30) of portions of plugs in variousconfigurations according to the invention.

DETAILED DESCRIPTION

The invention will now be described in further detail by reference tothe drawings, which illustrate alternative embodiments of the invention.The drawings are diagrammatic, showing features of the invention andtheir relation to other features and structures, and are not made toscale. For improved clarity of presentation, in the Figs. illustratingembodiments of the invention, corresponding elements shown in thevarious drawings are not all particularly renumbered, although they areall readily identifiable in all the Figs. Certain anatomical andhistological features, not necessary to an understanding of theinvention, are omitted from the Figs.

Turning now to FIG. 1, there is shown a diagrammatic sectional view thruthe spinal cord and associated structures, immediately followingplacement of a plug according to the invention within a puncture in thedura mater. The spinal dura mater 14 forms a sheath around the spinalcord 17. The spinal dura is underlain at its inner surface 21 by thearachnoid and the spinal cord is invested on its outer surface 16 by thepia mater. An epidural space 13 separates the dura 14 from the vertebralcanal, defined at the level of the sectional view of FIGS. 1 and 2 bythe vertebral body and, dorsally, by the ligamentum flavum 12. Thearachnoid is separated from the pia mater by the subarachnoid space 15,which is filled with cerebrospinal fluid.

Access to the subarachnoid space 15 can be obtained by passing a needleor catheter (not shown in FIG. 1 or 2) through the intervertebral spacebetween adjoining vertebrae. The needle or catheter penetrates throughthe skin and subcutaneous fatty tissues (not shown in the Figs.),through the ligamentum flavum 12, through the epidural space 13, andthrough the dura 14 into the subarachnoid space 15. When the needle orcatheter is withdrawn, an opening or rent 18 remains in the dura at thesite of the puncture.

According to the invention, a biocompatible and biodegradable plug 19 isplaced at the site of the rent. At least part of the plug 19 isswellable in tissue fluids, and, after a short time generally in a scaleof seconds or minutes, the plug swells in situ to form a barrier 20 thatoccludes the rent, as shown in FIG. 2. The plug is gradually degradedover a time sufficient to permit the rent to close by healing.

Some exemplary embodiments of plugs and of barriers formed in situ byswelling of the plugs according to the invention are shown in FIGS. 3-5,6-8, 9-11, and 12-18.

In the embodiment of FIG. 3, for example, the plug 30 has a dumbbellshape, with a pair of wider parts 32, 34 joined by a narrower connectingpart 36. The plug is placed at the site of the rent 28 such that onewider part 32 is in the volume 27 bounded by one surface of the membrane24 and the other wider part 34 is within the volume 29 bounded by theother surface of the membrane 24, and the connecting part 36 traversesthe rent 28. In this embodiment the connecting part as well as thelarger parts are made of a swellable material. Within a short timefollowing placement of the plug at the site of the rent (typically inthe order of a few seconds) the material swells to engage the edge 26 ofthe rent 28, occluding the opening. Particularly, as shown in FIG. 4,the medial regions 43, 45 of the wider parts 42, 44 swell against thesurfaces of the membrane 24 at the edge 26 of the rent. FIG. 5 shows abarrier 50 resulting from the continued swelling of the plug material atthe site of the rent. Here the medial regions 53, 55 of the swollenwider parts 52, 54 engage the surfaces of the membrane at the margin ofthe rent, securing the barrier and preventing it from migrating awayfrom the site. The barrier effectively obstructs movement or migrationof fluids in either direction from one of the volumes 27, 29 to theother across the rent.

Suitable swellable materials include biocompatible and biodegradablewater-swellable polymers, including for example hydrogels. The swellablematerial may be of biological origin, either derived from biologicaltissues or made biosynthetically; or it may be of nonbiological origin.Suitable materials include gelatins, collagens, celluloses, agaroses,hyaluronic acid (HA), poly(vinyl alcohol) (PVA), polyethylene oxide(PEO), and the like. Where the material is of biological origin it mustbe substantially free of active infectious agents, includingparticularly viruses and prions. The swellable material can be a foamedgel, or a sponge, or a nonwoven mesh or felt, or the like. As oneexample, a foamed gelatin material distributed by Pharmacea and Upjohnunder the name “GELFOAM®” may be particularly useful as a swellablematerial according to the invention.

The swellable material may include combinations of constituents thatslow or accelerate the swell rate, or increase or decrease the swellcapacity to suit a particular use. And the swellable material mayinclude combination of constituents that make the initially wettedsurface of the material more slippery, so that it can be more easilypassed through the lumen of a needle or catheter.

The connecting part of the plug may be made of a material different fromthat of the wider parts, and particularly, the connecting part may bemade of a non water swellable material. In the embodiment of FIG. 6, forexample, the plug 50 has a dumbbell shape, with a pair of wider parts62, 64 of a swellable material formed on a filament 66 of a nonswellable material. The plug is placed at the site of the rent 28 suchthat one swellable wider part 62 is within the volume 27 bounded by onesurface of the membrane 24 and the other swellable wider part 64 iswithin the volume 29 bounded by the other surface of the membrane 24,and 80 portion of the filament 66 between the connected swellable partstraverses the rent 28. Shortly, the swellable parts 72, 74 swell toengage the edge 26 of the rent 28, occluding the opening, as shown inFIG. 7. As shown in FIG. 8, a barrier 80 is formed as a result of thecontinued swelling of the plug material at the site of the rent. Here,the medial regions 83, 85 of the swollen parts 82, 84 engage thesurfaces of the membrane at the margin of the rent, securing thebarrier, generally as described with reference to FIG. 5.

Conveniently, a plug as shown in FIG. 6 is constructed by affixing anumber of swellable parts onto a filament at intervals as if attachingbeads on a strand, and then trimming the filament to form pairs ofswellable parts 62, 64 on a connecting part 66. In one example, a dryfoamed gelatin material may be cut to an appropriate size and thenmechanically compressed about the filament. The filament forming theconnecting part can be provided, for example, as a sterile strandprepared from collagen derived from healthy mammal (for example frombovine gut serosa); or a synthetic polymer, such as a polyglycolate, ora polylactate, or a polydioxanone, or the like. The filament may betreated to modify its stiffness, or its resistance to absorption, or itstendency to wick; it may be impregnated or coated with a suitableantimicrobial agent; or it may be colored by an approved color additive.Particularly, the filament can be a conventional absorbable suturematerial.

As will be appreciated, the strength and stiffness of such a filamentwill depend upon mechanical properties of the filament material and uponthe thickness (diameter; gauge) of the filament. In an embodiment as inFIG. 6, for example, the connecting function does not demand that thefilament be particularly strong or stiff. Any conventional suturematerial in any conventional suture gauge, for example, would beexpected to have sufficient tensile strength to maintain the connectionof the two swellable parts; and the plug need be only sufficiently stiffto maintain its orientation with respect to the rent during the earlierphase of swelling.

However, the placement of the plug at the site of the rent may befacilitated by providing a stiffer filament. In some embodiments of theinvention, as shown by way of example in FIG. 9, the plug 90 hasswellable parts 92, 94 affixed on a filament 96 as in the example ofFIG. 6; but here, the filament is preferably stiff and some length 98 ofthe filament is left intact, to provide for ready manipulation of theplug during placement. The length 98 of the filament can serve, forexample, as a stylet to guide the plug through tissues along a path tothe site of the rent. And, for example, the length 98 of the filamentcan serve to guide the plug within the lumen of a needle of cathetertoward the site of the rent. In other respects the plug 90 of FIG. 9 issimilar to the plug 60 of FIG. 6, and plug 90 forms a barrier 110through stages of swelling in a manner generally analogous to thatillustrated in FIGS. 7 and 8. The swellable parts of plug 90 swell sothat they 102, 204 engage the edge 26 of the rent as shown in FIG. 10and swell further so that medial regions 113, 115 of swollen parts 112,114 engage the surfaces of the membrane at the margins of the rent,securing the barrier 110, as shown in FIG. 11.

FIGS. 1, 3, 6 and 9 illustrate plug embodiments have a single pair ofconnected swellable wider portions, and for simplicity of presentationthe plug is shown as being symmetrically disposed within the rent. It isnot necessary that the plug be placed so that the plug axis (definedgenerally as a line running lengthwise through the connecting part) beoriented perpendicularly with respect to the membrane, nor that the plugaxis be centered within the rent. Nor is it necessary that the plug beplaced so that the two wider parts are equally distant from the plane ofthe rent. Orientation of the plug axis away from perpendicularity andout of center, and asymmetrical disposition of the wider parts withrespect to the plane of the rent, are acceptable because the swellingplug will tend to adjust its position within the rent as the wider partsswell to engage the membrane at the edge of the rent.

However, in order for a barrier to form successfully according to theinvention, occluding the rent as shown in FIGS. 2, 5, 8 and 11, the plugmust be placed so that the two wider portions are located on oppositesides of the membrane. If such a plug be advanced too far or not farenough, so that both swellable parts are in a space within the membraneor outside it, the wider parts will not engage the edge of the rent asthey swell, and no barrier will form at the rent.

In some instances, the rent site is hidden from view, and access to therent site is by way of the lumen of a needle or a catheter, or by way ofa path formed by a probe or blade. In such circumstances directinspection of the site cannot be employed to ensure that the plug isadvanced to an appropriate position within the rent. For example, nomethod is currently available for visualizing the rent site in a spinaldural puncture. Where the distance of the rent site from the insertionpoint at the surface of the subject's skin is known with sufficientaccuracy, appropriate placement may be made for example by employing aninsertion stylet having length indicia or, for an embodiment such as inFIG. 9, by employing length indicia on the extended length of thefilament, and orienting the length indicia to the skin surface. Or,where the plug is inserted through a catheter or needle, length indiciaon the stylet or filament can be aligned with indicia on the catheter orneedle to establish the position of the plug in relation to the needleor catheter tip. So long as the position of the tip of the needle orcatheter with respect to the membrane can be known with sufficientaccuracy, the plug may in some such embodiments be placed appropriatelyby ejecting it from the tip of the stylet prior to withdrawal of thestylet or the needle. Or, in other such embodiments where an extendedlength of the filament serves as a stylet, the plug is left in place andthe needle or catheter is withdrawn over the stylet. The use of lengthindicia is well known for stylets, needles, catheters, cannulae and thelike.

Alternatively, in some procedures where the rent is formed by a needleor catheter or the like, it may be possible to visualize the rent sitemore directly. For example, in preparation for a cranial dural puncture,a portion of the skull is removed near the site, so that the dura isexposed to view. In such instances a direct visual check on theplacement of the plug may be made.

As may be appreciated, where the plug has two connected swellableportions, increasing the distance between the wider parts can increasethe likelihood that the plug will be appropriately placed with theconnecting portion traversing the rent. The degree to which the widerparts can swell is limited, however, by the properties of the swellablematerial and, accordingly, the extent to which the wider parts may beseparated is also limited: if they are too far apart, then the swollenparts cannot securely engage the membrane surfaces at the margin of therent, and no barrier will be formed.

Alternatively, according to the invention, in some embodiments the plughas more than two wider swellable parts arranged in a string. Thisconfiguration increases the overall length of the swellable portion ofthe plug without increasing the spacing between pairs of wider swellableparts, and it improves the likelihood that when the plug is placed atthe rent site, a connected pair of wider swellable parts will beappropriately placed. For instance, where three wider swellable partsare provided, the overall length of the swellable portion is double thelength of a single pair of similarly spaced swellable parts; and eitherof two connecting pairs of swellable parts can find an appropriatelocation. Reference is made to FIG. 16, showing a plug 160 havingseveral swellable parts, seven of which (141, 143, 145, 142, 144, 147and 149) are shown in the Fig., arranged as beads on a filament 146. Theplug 160 is inserted through the rent 18 and placed such that at leastthe most distal one 141 of the swellable parts is known with areasonable certainty to be within the volume 27 on one side of themembrane 24, and such that at least one more proximal swellable part,for example 149, is known with a reasonable certainty to be within thevolume 29 on the other side of the membrane. That placement having beenaccomplished, the connecting portion between an adjacent pair ofswellable parts (between 142 and 144 in FIG. 16) is certain to traversethe rent. Then, as the swellable parts of the plug 160 swell, the medialregions 173, 175 of the swelling parts 172, 174 engage the edge 26 ofthe rent as shown in FIG. 17 and swell further so that medial portions183, 185 of swollen parts 182, 184 engage the surfaces of the membraneat the margins of the rent, securing the barrier 180, as shown in FIG.18.

Placement of a plug 160 according to one embodiment of the invention isillustrated in FIGS. 12 through 15. In FIG. 12 a dural needle 120 isshown, having a wall 122 and a lumen 124, and having an angled bevel 126at the tip. Techniques are well known for insertion of such a duralneedle so that the tip is placed for access to the cerebrospinal fluidwithin the subarachnoid space 27. The needle passes through (among otheranatomical features) the epidural space 29 and the dura 24, in which theneedle cuts an edge 26 defining a dural puncture. Generally, theoperator can feel the puncture of the dura as the needle is forcedthrough it (sometimes referred to as the dural “pop”), and care is takenas a matter of course not to advance the tip of the needle more than afew millimeters (or less) beyond that point. The needle 120 is placedfor any of a variety of purposes that call for access to thecerebrospinal fluid in the subarachnoid space: withdrawal of a sample ofCSF, for example, or introduction of an anesthetic. According to theinvention, the dural plug can be inserted by way of the lumen 124 of thesame needle 120 whose deployment created the dural puncture. A duralplug as shown for example in any of FIGS. 3, 6, 9 or 16 (or otherconfiguration within the scope of the invention) can be inserted withinthe lumen 124; FIGS. 13-15 illustrate placement of a plug having severalswellable parts serially spaced on a filament, as described above withreference to FIG. 16.

With the needle 120 deployed, as described with reference to FIG. 12,the plug 160 is passed within the lumen 124 toward the tip of the needle120, as indicated by arrow 130 in FIG. 13. As shown in FIG. 13, the plug160 includes several swellable parts (e.g., 132, 134) affixed atintervals on a filament 136. The filament 136 is sufficiently stiff thatit serves to maintain the spacing and the axial alignment of theswellable parts as the plug is passed through the needle. A separatestylet or other pusher (not shown) may be employed to press the plugthrough the needle. Or, a proximal extended length of the filament (notshown in FIGS. 13-18) may serve as a stylet, as described with referenceto FIG. 9. The pusher or stylet or extended length of the filament maybe marked with length indicia, so that the progress of the plug towardthe tip of the needle may be monitored. The plug is advanced until, asis shown for example in FIG. 14, the operator is reasonably certain thatat least the most distal swellable part 141 is inside the membrane(within the subarachnoid space in this illustration) and that at leastone more proximal swellable part (e.g., 149) is within a section of theneedle that is outside the membrane (in the epidural space in thisillustration). This can be accomplished, for example, by employing aplug whose swellable portion (series of swellable parts) has an overalllength greater than any likely distance that the tip of the needle isdeployed beyond the membrane, and advancing the plug within the needlejust to the point that the most distal swellable part 141 is locatedapproximately at the tip, as illustrated in FIG. 14.

Then the needle is withdrawn as indicted by the arrow 150 in FIG. 15,while the position of the plug 160 is maintained. As will be apparent,if the needle were deployed more or less deeply beyond the rent than isshown in this illustration, or if the plug were advanced more or lessfar within the needle than is shown, then a different connected pair ofswellable portions would have come into play in the formation of thebarrier. Although the operator cannot determine precisely where alongthe length of the plug a connecting part between an adjacent pair ofswellable portions will traverse the rent, it is reasonably certain thatsuch will somewhere occur, in a connecting portion (146 as illustratedhere) between some pair (here 142, 144) of adjacent swellable partsbetween the most distal one (141) and the more proximal one (e.g. 149).The swellable parts of the plug swell in situ to form the barrier asdescribed above with reference to FIGS. 16-18.

The plug is represented in the foregoing Figs. as having spheroidal orspherical swellable parts or beads. FIGS. 19 and 20 are sectional viewsshowing a portion of such a plug 190, including several swellable partsand connecting parts between them, marked for illustration of a range ofdimensions that the various features of the plug may have according tothe invention. FIG. 19 is a lengthwise sectional view made along an axisA defined by the centerline of the connecting part or filament 196, andFIG. 20 is a sectional view through a swellable part or bead (e.g., 192or 194) in a plane transverse to the axis A. The connecting part orfilament 196 has a diameter F, and the swellable parts or beads 192, 194have a transverse width W as measured in the plane T transverse to theaxis A. Adjacent swellable parts or beads 192, 194 are spaced apart by apitch P measured lengthwise between respective points 193, 195 ofgreatest transverse width.

Where the plug is to be deployed by passing a within the lumen of theneedle or catheter, the transverse width W is determined by the lumenaldimension, that is, by the inside diameter of the needle or catheter.Generally, the greatest transverse width W must be somewhat smaller thanthe inside diameter, so that the plug may be passed through the lumen ofthe needle or catheter with little or no frictional resistance. Thedimensions of the defect in the membrane depend particularly upon theoutside diameter of the needle that was used to create the puncture, aswell as the configuration of the tip of the needle and techniqueemployed. In order to form a secure barrier, the deployed plug will haveto be capable of swelling to engage the membrane at the rent, asdescribed with reference to for example to FIGS. 4 and 5. Accordingly,it can be advantageous to use a plug having the largest transverse widthW that can pass the lumen of the needle, and to select a needle having athinner rather than a thicker wall. And, accordingly, it can beadvantageous to form the swellable parts or beads of the material havinga greater rather than a lesser dimensional swell capacity.

The pitch P is determined by consideration of the size of the swellableparts or beads and of the dimensional swell capacity of the material ofwhich they are made. That is, referring again to FIG. 3-5, the pitch isdetermined such that as the swellable material swells (FIG. 4) themedial regions 43, 45 of the swelling parts 42, 44 swell against thesurfaces of the membrane 24 at the edge of the rent, and then continueto swell (FIG. 5) until the medial regions 53, 55 of the swelling parts52, 54 engage the surfaces of the membrane at the margin of the rent,securing the barrier. If the swellable parts or beads are made of amaterial having a lower dimensional swell capacity, then the beads canbe pitched closer together to achieve this result.

The series of swellable parts or beads constitute the swellable portion191 of the plug 190. The length L of the swellable portion 191 of theplug 190 is determined by the number of swellable parts or beads and bythe spacing between them. As explained above with reference to FIGS. 12to 18, the length L is selected to assure that, within a reasonablecertainty, the connecting part between an adjacent pair of swellableparts or beads will traverse the rent following deployment of the plugat the site. That is, given a preferred pitch P, the swellable portionof the plug will include a sufficient number of swellable parts or beadsto provide a length L that will span the greatest likely margin of errorin positioning the plug at the site.

As noted earlier, the swellable parts of the plug according to theinvention may have any of a wide variety of shapes. What is required isthat at least two connected wider swellable parts have a narrower regionbetween them, so that the plug can be placed at the rent site such thatthe wider parts are situated on opposite sides of the membrane or wall,with the narrower region traversing the rent.

FIGS. 21-30 show a few illustrative examples of suitable configurations.For ease of reference, each of FIGS. 21, 23, 25, 27 and 29 is a sideview of a portion of two connected wider adjacent swellable parts orbeads of a plug body according to an embodiment of the invention, andeach of FIGS. 22, 24, 26, 28 and 30 is an axial view (along A-A taken asindicated) of one of the wider swellable parts or beads. In each ofFIGS. 21, 23, 25, 27 and 29, T indicates a plane transverse to the axisA-A at the place where the width of a wider swellable part or bead isgreatest, and only that portion of the swellable parts or beads that isbetween the planes T is shown. In each embodiment, the plug is narrowerbetween the wider swellable parts or beads. Also, is was describedearlier, the swellable portion of a plug according to the invention mayhave more than two wider swellable parts or beads, although portions ofonly two adjacent ones are shown here. As may be appreciated, each widerswellable part or bead may be symmetrical with respect to the plane T,but it is not necessarily so; also, adjacent wider swellable parts orbeads may be similarly shaped, as is shown in these Figs., but adjacentwider swellable parts or beads may according to the invention be shapeddifferently.

By way of example, FIG. 21 shows a portion of two swellable beads 212,214 connected on a non-swellable filament 216. Each bead is elongatedaxially toward the adjacent bead, so that each bead tapers from itswider point 213, 215 toward the filament 216. In such an embodiment, asin the embodiment shown in FIGS. 19 and 20, the narrower region betweenthe wider points of the beads is the diameter of the filament; but inthis embodiment a transition between the wider and narrower regions ismore gradual than is provided by the spherical or spheroidal beadconfiguration as in FIG. 19.

Rather than being rounded in side view at its widest point, as shown forexample in FIG. 21, each bead may have an edge or rim, as shown forexample in FIG. 23. In this example each of the illustrated beadportions 232, 234 is generally conical, tapering from its widest point233, 235 toward the filament 236. In an example such as this, in thecase where the plug is deployed with the opening in the membrane veryclose to the widest point of a bead, the plug may self-adjust as itswells, moving axially in one direction or the other to capture themembrane or wall between adjacent beads more effectively than would aplug having a more rounded configuration as shown for example in FIG. 19or FIG. 21. In this embodiment, as in an embodiment as shown for examplein FIG. 21, the narrower region between the adjacent-beads is thediameter of the filament.

As illustrated for example in FIG. 25, the narrower region 257 betweenadjacent wider swellable parts 252, 254 may, in some embodiments, haveswellable material surrounding the filament 256. This may increase thecapacity of the swellable material to effectively fill the rent,particularly in applications where the wall or membrane is thicker andthe beads or wider swellable portions are more widely spaced apart. Thatis, it is not necessary nor is it in some applications desirable thatthe narrower region be as narrow as the filament; in practice it needonly be narrow enough to permit the adjacent swellable parts to engagethe surfaces of the wall or membrane at the margin of the rent, andthereby securing the barrier in place within the rent site.

FIGS. 22, 24 and 26 show the bead as circular at its widest point andcentered at the axis of the filament. It may according to the inventionbe round or rounded yet non-circular, for example oval or ovoid. Or,other shapes are possible according to the invention, as FIGS. 27-30show by way of illustration.

In the examples shown in FIGS. 27-30, rather than having a circulartransverse section, each bead may have a polygonal shape at its widestpoint (hexagonal in the Figs., by way of example), so that each of theillustrated bead portions has a pyramidal or truncated pyramidal shape.Thus, each of bead portions 272, 274 in FIGS. 27 and 28 has a polygonal(hexagonal) shape at the wider point 273, 275 and then tapers as apyramid to a truncation point, e.g., 277. The narrower point in thisembodiment is the diameter of the filament 276, and the filament 276 isbare over a significant part of the separation between the beads, and inthis respect is similar to a configuration having spheroidal beads on afilament as illustrated in FIG. 19. In FIGS. 29 and 30 each of beadportions 292, 294 has a polygonal (here hexagonal) shape at the widerpoint 293, 296 and then tapers as a truncated pyramid; but here thepyramids meet at the narrower point 297, to provide some swellablematerial surrounding the filament 296.

Still other shapes are contemplated according to the invention. As willbe appreciated, the wider swellable portions need not be as regularlyshaped as illustrated here, nor need they be precisely formed.

Generally, the invention can be useful in surgical procedures in thefields of endoscopy, laparoscopy, orthoscopy, bronchoscopy, and others.For example, the aorta may be accessed from within the stomach by way ofa puncture through the stomach wall, using an esophageal endoscope;according to the invention, a barrier can be formed in the rent in thestomach wall at the completion of the procedure. Similarly, incircumstances in which a transurethral catheter cannot be placed, asuperpubic puncture of the urinary bladder may be made; a barrier can beformed according to the invention to prevent leakage of urine into theperitoneal cavity through the rent in the bladder wall.

The invention can also be employed in conjunction with any of a varietyof medical procedures in which a puncture or rent is formedunintentionally. For example, an unintentional puncture may occur in thecourse of any of various minimally invasive procedures involving accessby way of the lumen of a hollow organ of the body, as for example invarious procedures in urology or gastroenterology; such complicationsare regrettably high, but can be mitigated by using a barrier formedaccording to the invention to control movement of fluids or fluid-bornematerials through the puncture.

Other embodiments are within the following claims.

1. A method for limiting fluid movement through a rent in a membranoustissue in a body, comprising placing within the rent a plug thatincludes connected water-swellable parts.
 2. The method of claim 1wherein placing the plug within the rent comprises passing the plug tothe rent within a lumen of a catheter extending from an introductionsite through intervening tissue to the site of the rent, and wherein themembrane comprises a dura mater and the rent is a dural defect.
 3. Amethod for limiting fluid movement through a rent in the dura mater,comprising providing a plug comprising swellable parts joined by aconnector, and placing the plug within the rent such that at least oneof the swellable parts is within a subarachnoid space and at least oneother one of the swellable parts is positioned in an epidural space, andthe connector traverses the rent in the dura mater, wherein placing theplug within the rent comprises passing the plug to the rent within alumen of a catheter extending from an introduction site throughintervening tissue to the site of the rent.
 4. The method of claim 3wherein the rent is an intracranial dural defect.
 5. The method of claim2 wherein the membrane comprises a dura mater and the rent is a duraldefect.
 6. The method of claim 5 wherein the rent is an intraspinaldural defect.
 7. The method of claim 5 wherein the rent is anintracranial dural defect.
 8. A biocompatible and physiologicallydegradable plug body for insertion into a tissue rent for forming abarrier to fluid movement through the rent, comprising a swellableportion including at least two connected water-swellable parts.
 9. Theplug body of claim 8 wherein the water-swellable parts are end portionsof a dumbbell-shaped body formed entirely of a water-swellable material.10. The plug body of claim 8 wherein the water-swellable parts are beadsformed on a connecting filament.
 11. The plug body of claim 8 whereinthe swellable parts are formed of a material selected so that theswellable parts can increase in size by at least 1.2 times in atransverse dimension.
 12. The plug body of claim 8 wherein the swellableparts are formed of a material selected so that the swellable parts canincrease in size by at least 1.5 times in a transverse dimension. 13.The plug body of claim 8 wherein the swellable parts are formed of amaterial selected so that the swellable parts can increase in size by atleast 2 times in a transverse dimension.
 14. The plug body of claim 8wherein the swellable parts are formed of a material selected so thatthe swellable parts can increase in size by 1.2 to 3 times in atransverse dimension.
 15. The plug body of claim 8 wherein the swellableparts are formed of a material comprising a biocompatible andbiodegradable water-swellable polymer.
 16. The plug body of claim 8wherein the swellable parts are formed of a material comprising awater-swellable polymer of biological origin.
 17. The plug body of claim15 wherein the water-swellable polymer comprises a gelatin, a collagen,a cellulose, an agarose, a hyaluronate, or a combination thereof. 18.The plug body of claim 15 wherein the water-swellable polymer is derivedfrom biological tissue.
 19. The plug body of claim 15 wherein thewater-swellable polymer is made by a biosynthesis process.
 20. The plugbody of claim 15 wherein the swellable parts are formed of a materialcomprising a water-swellable polymer of nonbiological origin.
 21. Theplug body of claim 20 wherein the water-swellable polymer comprises apoly(vinyl alcohol), a polyethylene oxide, or a combination thereof. 22.The plug body of claim 8 wherein the swellable parts are formed of amaterial comprising a foamed gel, or a sponge or mesh.
 23. The plug bodyof claim 8 wherein the swellable parts are formed of a materialcomprising a hydrogel.
 24. The plug body of claim 10 wherein theconnecting filament is formed of a biocompatible and biodegradable nonwater-swellable material.
 25. The plug body of claim 24 wherein theconnecting filament is formed of a material comprising a biocompatibleand biodegradable non water-swellable polymer.
 26. The plug body ofclaim 25 wherein the non water-swellable polymer comprises apolyglycolate or a polylactate or a polydioxanone, or a combinationthereof.
 27. The plug body of claim 10 wherein the filament is amonofilament.
 28. The plug body of claim 10 wherein the filament is asterile filament prepared from collagen derived from a healthy mammal,capable of being biodegraded by living mammalian tissue.
 29. The plugbody of claim 10 wherein the filament is a sterile synthetic polymerfilament, capable of being biodegraded by living mammalian tissue. 30.The plug body of claim 10 wherein the filament comprises an absorbablesuture material.
 31. The plug body of claim 10 wherein the waterswellable parts have a generally spheroidal shape.
 32. The plug body ofclaim 10 wherein the water swellable parts are elongated in an axialdirection.
 33. The plug body of claim 10 wherein the water swellableparts have a polygonal shape.
 34. The plug body of claim 10 wherein thewater swellable parts have a discoid shape.
 35. The plug body of claim10 wherein the water swellable parts have an ovoid shape.
 36. The plugbody of claim 8 wherein the swellable parts are small enough in adimension transverse to a lengthwise axis of the plug body so that theplug body can be passed readily within the lumen of a selected needle orcatheter.
 37. The plug body of claim 8 wherein a maximum transversedimension of the swellable parts is less than 1.5 millimeters.
 38. Theplug body of claim 8 wherein a maximum transverse dimension of theswellable parts is less than 0.2 millimeters.
 39. The plug body of claim8 wherein the swellable portion has a length at least 6 millimeters. 40.The plug body of claim 39 wherein the swellable portion has a length atleast 10 millimeters.
 41. The plug body of claim 8 wherein the swellableportion has a length at most 20 millimeters.
 42. The plug body of claim41 wherein the swellable portion has a length at most 12 millimeters.43. The plug body of claim 8 wherein the swellable portion has a lengthin the range 10 to 12 millimeters.
 44. The plug body of claim 10 whereinthe connecting filament is sufficiently stiff that it can serve as astylet.
 45. The plug body of claim 10 wherein the connecting filamentextends axially for a length beyond the swellable portion.
 46. Themethod of claim 1 wherein the rent is a defect in a wall of thegastrointestinal tract.
 47. The method of claim 1 wherein the rent is adefect in a wall of the urinary bladder.